Chronic GVHD
Showing 1 - 25 of >10,000
Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)
Active, not recruiting
- Hematologic Malignancy
- Tacrolimus
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital
Jan 31, 2023
GVHD, Chronic, Hematological Malignancy Trial in Copenhagen (Lee Symptom Scala)
Active, not recruiting
- GVHD, Chronic
- Hematological Malignancy
- Lee Symptom Scala
-
Copenhagen, DenmarkRigshospitalet
Jul 14, 2022
Chronic GVHD Response Measures Validation
Active, not recruiting
- Graft vs Host Disease
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Feb 28, 2022
Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))
Active, not recruiting
- Chronic Graft-versus-host-disease
- Itacitinib
- Extracorporeal Photopheresis (ECP)
-
Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
Jan 30, 2023
Dendritic Cells in Acute or Chronic Skin Graft Versus Host
Recruiting
- Acute Graft-versus-host Disease
- +3 more
- Skin punch biopsy
- Peripheral blood draw
-
Saint Louis, MissouriWashington University School of Medicine
May 31, 2022
GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))
Recruiting
- Graft Versus Host Disease
- Cyclophosphamide
- anti-human T-lymphocyte immunoglobulin (ATLG)
-
Ramat Gan, IsraelChaim Sheba Medical Center
May 4, 2022
Testing for Chronic Graft Versus Host Disease, CATCH Study
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Biospecimen Collection
- +6 more
-
Gainesville, Florida
- +6 more
Jan 25, 2023
Improving Outcomes Assessment in Chronic GVHD
Active, not recruiting
- Chronic Graft Versus Host Disease
-
Stanford, California
- +8 more
Mar 9, 2022
Chronic GVHD, Allogeneic Stem Cell Transplant Trial in Boston (App, Usual Care)
Recruiting
- Chronic Graft-Versus-Host Disease
- Allogeneic Stem Cell Transplant
- App
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 24, 2023
Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Immune Mediated Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Ocular Surface Disease in Chronic Graft-Versus-Host Disease
Recruiting
- Dry Eye
- GVHD
- Cross-sectional study
-
Singapore, SingaporeCynthia Boo
Mar 22, 2022
Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Immune Mediated Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Stem Cell Transplant Complications, Graft Vs Host Disease, Coping Skills Trial in Boston (Horizon Program, Usual Care)
Recruiting
- Stem Cell Transplant Complications
- +3 more
- Horizon Program
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Aug 31, 2021
GVHD,Acute, GVHD, Chronic Trial in Salamanca (Physical exercise)
Recruiting
- GVHD,Acute
- GVHD, Chronic
- Physical exercise
-
Salamanca, SpainUniversity of Salamanca
May 27, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis
Not yet recruiting
- Bone Marrow Transplant Complications
- +4 more
- Sitagliptin
- +2 more
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
May 30, 2023
GVHD, Allogeneic Hematopoietic Cell Transplant Recipient Trial in Palo Alto (Regulatory T Cells)
Completed
- Graft Versus Host Disease
- Allogeneic Hematopoietic Cell Transplant Recipient
- Regulatory T Cells
-
Palo Alto, CaliforniaStanford University, School of Medicine
Sep 20, 2021
Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease Trial in Boston (Exercise, Attention
Recruiting
- Graft Vs Host Disease
- +2 more
- Exercise
- Attention control
-
Boston, Massachusetts
- +1 more
Nov 28, 2022
Hematopoietic Stem Cell Transplantation, Multiple Myeloma Trial in Spain (Ixazomib, Tacrolimus, Sirolimus)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma
- Ixazomib
- +3 more
-
Badalona, Spain
- +7 more
May 20, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 1, 2022
GVHD, GVHD, Undefined Trial in United States (Photobiomodulation Therapy, Placebo sham device)
Recruiting
- Graft-Versus-Host Disease
- +2 more
- Photobiomodulation Therapy
- Placebo sham device
-
Bethesda, Maryland
- +8 more
Jan 17, 2023
Musculoskeletal Disease Other, GVHD, Chronic Trial in Navi Mumbai (Leflunomide tablet)
Recruiting
- Musculoskeletal Disease Other
- GVHD, Chronic
- Leflunomide tablet
-
Navi Mumbai, Maharashtra, IndiaTata Memorial Centre, Advanced Centre for Treatment, Research an
Jun 18, 2021